Menu
Back to Journals » OncoTargets and Therapy » Volume 12
RETRACTED ARTICLE: Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells
Authors Hu C, Zhuang W, Qiao Y, Liu B, Liu L, Hui K, Jiang X
Received 5 September 2018
Accepted for publication 17 December 2018
Published 29 January 2019 Volume 2019:12 Pages 933—944
DOI https://doi.org/10.2147/OTT.S186559
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Arseniy Yuzhalin
This paper has been retracted.
Hu C, Zhuang W, Qiao Y, et al. Onco Targets Ther. 2019;12:933–944.
The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of western blot images in Figure 2. Specifically,
- Figure 2, A1, GAPDH bands, appear to have been duplicated with the same bands from Figure 2, C1, Cyclin D1.
The authors responded to our queries but were unable to provide a satisfactory explanation for the alleged duplication, nor were they able to provide original data that could adequately verify the findings. The Editor requested to retract the article and the authors do not agree with this decision.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.